ALB and respiratory failure: The gross excess of respiratory failure in the terlipressin group was despite more diuretic use in the terlipressin group at 25.5% versus 13.1%,2 the placebo group receiving larger doses of albumin both before and after randomization, and 17% of the terlipressin group getting no additional albumin after randomization.